We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Digital Breast Tomosynthesis Reduces Patient Recall Rates by 40%

By HospiMedica International staff writers
Posted on 22 May 2012
Adding digital breast tomosynthesis to two-dimensional (2D) mammography screening results in a 40% reduction in patient recall rates compared to routine screening mammography alone, new findings have revealed. More...


The study conducted at Yale University School of Medicine (New Haven, CT, USA) involving 7,578 screening mammograms found that the recall rate was 6.6% for digital breast tomosynthesis plus 2D screening mammography. It was 11.1% for 2D screening mammography alone, according to Melissa Durand, MD, one of the authors of the study.

Similar recall rates were seen in both groups for masses, but the recall rate was significantly lower with digital breast tomosynthesis and 2D mammography compared to 2D mammography alone for asymmetries and calcifications, according to Dr. Durand. The recall rate was 2.8% for asymmetries when both techniques were used compared to 7.1% for routine screening mammography.

“Tomosynthesis, which is 3D mammography, allows us to look at the breast in 1 mm slices. In routine mammography, breast tissue is compressed and overlying tissue can look like a suspicious finding. Tomosynthesis resolves this by looking slice by slice,” said Liane Philpotts, MD, another study author.

The radiation dose for the combined examination is below the US Food and Drug Administration (FDA) limit for mammography and below the dose of film mammography, noted Dr. Durand. “For now we are doing both examinations, but it may not be long before we will be able to do just the tomosynthesis exam. Researchers are working on ways to get a 2D image out of the 3D data, and when that happens, there may be no need for the 2D examination,” Dr. Philpotts said.

“Recalls from screening mammography incite considerable anxiety in women. With digital breast tomosynthesis, we are seeing a dramatic reduction in our recall rates, which helps lessen our patients’ anxiety. Fewer recalls means fewer additional breast imaging views, which is cost saving and may also reduce overall annual radiation dose,” said Dr. Durand.

The study’s findings were presented May 7, 2012, at the American Roentgen Ray Society annual meeting in Vancouver (BC, Canada).

Related Links:
Yale University School of Medicine



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
Digital Radiography System (Ceiling Free)
Digix CF Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.